Learn about clinical trials that are currently recruiting.

— Phase 3 NASH Study
— Phase 4 PBC Study
— Phase 2 Biliary Atresia Study


At Intercept, our work is motivated by our desire to help patients and families who struggle with chronic liver diseases and need better treatment options.


Alkaline phosphatase (ALP): One of several chemicals in the body that can be used to diagnose primary biliary cirrhosis (PBC) and track the progression of the disease.
Antimitochondrial antibodies (AMAs): A chemical in the body that can be used to diagnose PBC.
Autoimmune disease: A condition in which the body attacks a part of itself.
Bile duct: A tube-like structure in the liver that transports bile to the small intestine to help with digestion.
Cirrhosis: Severe scarring of the liver.
Fibrosis: Excess connective tissue in an organ that can lead to damage.
Jaundice: The yellow appearance of the skin and eyes that can be caused by liver failure.
Pruritus: Itching of the skin, a common symptom of PBC.

You are now leaving interceptpharma.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents. Intercept provides this link as a service to its website visitors. Intercept is not responsible for the content or the privacy policy of any third party websites.

Close this window to return to Intercept Pharma’s site or click ‘Continue’ to proceed. 

You are now being redirected to Intercept's job application site, hosted by a third party.